Product
Liposomal mitoxantrone
Aliases
Dose-finding stage: Liposomal mitoxantrone hydrochloride, Cyclophosphamide, Vincristine and Prednisone, Part1, Part 1, Part 1: Liposomal mitoxantrone hydrochloride and Pegaspargase
3 clinical trials
5 indications
Indication
Extranodal NK/T-cell LymphomaIndication
Nasal TypeIndication
Treatment-naïveIndication
Peripheral T Cell LymphomaIndication
Diffuse Large B-Cell LymphomaClinical trial
A Multicentre, Open-label, Single-arm, Phase I/II Clinical Study to Evaluate the Safety, Efficacy and Pharmacokinetic Characteristics of Liposomal Mitoxantrone Hydrochloride Injection Combined With Pegaspargase in the Treatment of NKTCLStatus: Terminated, Estimated PCD: 2022-01-30
Clinical trial
Clinical Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of Liposomal Mitoxantrone Hydrochloride Injection Combined With Cyclophosphamide, Vincristine and Prednisone in the Treatment of Untreated PTCLStatus: Terminated, Estimated PCD: 2023-06-30
Clinical trial
A Phase 2 Study of Chidamide, Azacitidine Combined With GM Regimen for Patients With Relapsed and Refractory DLBCLStatus: Recruiting, Estimated PCD: 2023-12-31